Cordis was founded in Miami, Florida, by Dr. William Murphy about 50 years ago, and became well known in the global medical industry, as its name meant innovation, quality and reliability to its end-users.
Currently, Cordis’ revenue is approximately $800M, and its primary products are balloon catheters designed for the diagnosis and treatment of blockages in blood vessels, implantable vascular & Abdominal Aortic Aneurysm stents, and vascular access closure (plugs the access area made in the vessel) devices.
Cordis historically has had its headquarters in Fremont, CA (south of San Francisco) has two manufacturing sites, one in Miami Lakes, FL, and one in Juarez, Mexico. The Fremont site, is home for the several key functions, like R&D, Engineering, Finance, Quality and Regulatory Affairs, Legal, Global Sourcing, Customer Services, and other groups. In addition, the Fremont site is outfitted with labs designed for product innovation and testing.
The Miami Lakes plant is highly automated and focused on the conversion of raw materials, mainly resins, into complex compounds used in the manufacturing of large number of extruded tubing, some of which are braided with stainless steel threads. These tubes are key components of the catheter and stent delivery systems, and others are designed specifically for the manufacture of the angioplasty balloons.
The Juarez site employs over 1,500 employees dedicated to the manufacture of FG. While the Miami plant supplies 100% of its products as components to its sister plant in Mexico, other RM and component suppliers provide their products directly to Mexico as well.
In addition to self-manufacturing, Cordis acquires FG from other C&V suppliers out of the US, EU and Asia. The Global Sourcing team, located in both Miami Lakes and Fremont, are responsible managing the supplier relationship and acquisition of RM/Components and FG from their supplier community, globally.
Access Closure Inc., a manufacturer of the Mynx products, which is also a vascular entry-point closure device, is now part of Cordis Corp.
So what does the future hold? Growth. Key growth pillars are new product introductions, improvements to the existing base products, further acquisitions and expanding customer offerings with Cardinal Health’s broad medical device portfolio at a global scale.